Identification of minimal peptide sequences in the (8-20) domain of human islet amyloid polypeptide involved in fibrillogenesis

Journal of Structural Biology

Volumn 141, Issue 3, 2003, Pages 218-227

  Scrocchi, Louise A ^a   Ha, Kathy ^a   Chen, Yan ^a   Wu, Ling ^a   Wang, Feng ^a   Fraser, Paul E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Amyloid fibrils; Circular dichroism; Cytotoxicity; Diabetes; Electron microscopy; Islet amyloid polypeptide (IAPP)

Indexed keywords

AMYLIN DERIVATIVE; AMYLOID; HEXAPEPTIDE; LEUCYLALANYLASPARAGINYLPHENYLALANYLLEUCYLVALINE; PEPTIDE FRAGMENT; PHENYLALANYLLEUCYLVALYLHISTIDYLSERYLSERINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BETA SHEET; CELL CULTURE; CIRCULAR DICHROISM; CONTROLLED STUDY; CYTOTOXICITY; ELECTRON MICROSCOPY; FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; PROTEIN PROTEIN INTERACTION; RAT; SEQUENCE ANALYSIS; STAINING;

EID: 0037341842     PISSN: 10478477     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-8477(02)00630-5     Document Type: Article

References (27)

1. Azriel R., Gazit E. Analysis of the minimal amyloid-forming fragment of the islet amyloid polypeptide. J. Biol. Chem. 276(36):2001;34156-34161.
2. Blanchard B.J., Konopka G., Russell M., Ingram V.M. Mechanism and prevention of neurotoxicity caused by β-amyloid peptides: relation to Alzheimer's disease. Brain Res. 776:1997;40-50.
3. Clark A., Edwards C.A., Ostle L.R., Sutton R., Rothbard J.B., Morris J.F., Turner R.C. Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human β-cells and in islets of type 2 diabetic subjects. Cell Tissue Res. 257:1989;179-185.
4. Glenner G.G., Eanes E.D., Wiley C.A. Amyloid fibrils formed from a segment of the pancreatic-islet amyloid protein. Biochem. Biophys. Res. Commun. 155:1988;608-614.
5. Goldsbury C., Goldie K., Pellaud J., Seelig J., Frey P., Muller S.A., Kistler J., Cooper G.J.S., Aebi U. Amyloid fibril formation from full-length and fragments of amylin. J. Struct. Biol. 130:2000;352-362.
6. Griffiths J.M., Ashburn T.T., Auger M., Costa P., Griffin R.G., Lansbury P.T. Jr. Rotational resonance solid-state NMR elucidates a structural model of pancreatic amyloid. J. Am. Chem. Soc. 117:1995;3539-3546.
7. Higham C.E., Jaikaran E.T.A.S., Fraser P.E., Gross M., Clark A. Preparation of synthetic human islet amyloid (IAPP) in a stable conformation to enable study of conversion to amyloid-like fibrils. FEBS Lett. 470:2000;55-60.
8. Jaikaran E.T.A.S., Higham C.E., Serpell L.C., Zurdo J., Gross M., Clark A., Fraser P.E. Identification of a novel human islet amyloid polypeptide β-sheet domain and factors influencing fibrillogenesis. J. Mol. Biol. 308:2001;515-525.
9. Janciauskiene S., Ahren B. Different sensitivity to the cytotoxic action of IAPP fibrils in two insulin-producing cell lines, HIT-T15 and RIN5mF cells. Biochem. Biophys. Res. Commun. 251:1998;888-893.
10. Janson J., Ashley R.H., Harrison D., McIntyre S., Butler P.C. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes. 48:1999;491-498.
11. Kahn S.E., Andrikopoulos S., Verchere C.B. Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes. Diabetes. 48:1999;241-253.
12. Kapurniotu A., Schmauder A., Tenidis K. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity. J. Mol. Biol. 315:2002;339-350.
13. Kayed R., Bernhagen J., Greenfield N., Sweimeh K., Brunner H., Voelter W., Kapurniotu A. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 287:1999;781-796.
14. Lorenzo A., Razzaboni B., Weir G.C., Yankner B.A. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature. 368:1994;756-760.
15. Lukinius A., Wilander E., Westermark G.T., Engstrom U., Westermark P. Co-localisation of islet amyloid polypeptide and insulin in the β-cell secretory granules of the human pancratic islets. Diabetologia. 32:1989;240-244.
16. Moriarty D.F., Raleigh D.P. Effects of sequential proline substitutions on amyloid formation by human amylin 20-29. Biochemistry. 38:1999;1811-1818.
17. Nilsson M., Raleigh D. Analysis of amylin cleavage products provides new insights into the amyloidogenic region of human amylin. J. Mol. Biol. 294:1999;1375-1395.
18. Padrick S.B., Miranker A.D. Islet amyloid polypeptide: identification of long-range contacts and local order on the fibrillogenesis pathway. J. Mol. Biol. 308:2001;783-794.
19. Park K., Verchere B. Identification of a heparin binding domain in the N-terminal cleavage site of pro-islet amyloid polypeptide. J. Biol. Chem. 20:2001;16611-16616.
20. Rhoades E., Agarwal J., Gafni A. Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide. Biochim. Biophys. Acta. 1476:2000;230-238.
21. Scrocchi L.A., Chen Y., Waschuk S., Wang F., Cheung S., Darabie A.A., McLaurin J., Fraser P.E. Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis. J. Mol. Biol. 318:2002;697-706.
22. Selkoe D.J. Alzheimer's disease: genotypes, phenotypes, and treatments. Science. 275:1997;630-631.
23. Tenidis K., Waldner M., Bernhagen J., Fischle W., Bergmann M., Weber M., Merkle M.-L., Voelter W., Brunner H., Kapurniotu A. Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. J. Mol. Biol. 295:2000;1055-1071.
24. Tjernberg L.O., Lilliehook C., Callaway D.J.E., Naslund J., Hahne S., Thyberg J., Terenius L., Nordstedt C. Controlling amyloid β-peptide fibril formation with protease-stable ligands. J. Biol. Chem. 272:1997;12601-12605.
25. Westermark P., Engstrom U., Johnson K.H., Westermark G.T., Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc. Natl. Acad. Sci. USA. 87:1990;5036-5040.
26. Westermark P., Wilander E., Westermark G.T., Johnson K.E. Islet amyloid polypeptide-like immunoreactivity in the islet β cells of type 2 (non-insulin-dependent) diabetic and non-diabetic individuals. Diabetologia. 30:1987;887-892.
27. Westermark, Pl., (1994). Amyloid and polypeptide hormones: what is their relationship? Amyloid 1, 47-60.